Lista de obras - Shan Lu - Dominio Público Uruguay

A DNA vaccine producing LcrV antigen in oligomers is effective in protecting mice from lethal mucosal challenge of plague

artículo científico publicado en 2004

A versatile vector for the production of pseudotyped viruses expressing gp120 antigens from different clades of primary HIV-1 isolates.

artículo científico publicado en 2010

Antibody responses elicited through homologous or heterologous prime-boost DNA and protein vaccinations differ in functional activity and avidity.

artículo científico publicado en 2010

Antigen engineering can play a critical role in the protective immunity elicited by Yersinia pestis DNA vaccines.

artículo científico publicado en 2010

Antigen engineering in DNA immunization

artículo científico publicado en 2000

Clostridium difficile infections in China.

artículo científico publicado en 2010

Co-expression of HIV-1 virus-like particles and granulocyte-macrophage colony stimulating factor by GEO-D03 DNA vaccine

artículo científico publicado en 2012

Combination DNA plus protein HIV vaccines.

artículo científico publicado en 2006

Construction and evaluation of replication-defective recombinant optimized triosephosphate isomerase adenoviral vaccination in Schistosoma japonicum challenged mice

artículo científico publicado en 2014

Cross-clade neutralizing antibodies against HIV-1 induced in rabbits by focusing the immune response on a neutralizing epitope.

artículo científico publicado en 2009

Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime-protein boost HIV-1 vaccine in healthy human volunteers

artículo científico publicado en 2008

DNA Immunization for HIV Vaccine Development

artículo científico

DNA immunization

artículo científico publicado en 2013

DNA prime-protein boost using subtype consensus Env was effective in eliciting neutralizing antibody responses against subtype BC HIV-1 viruses circulating in China.

artículo científico publicado en 2012

DNA vaccine prime followed by boost with live attenuated virus significantly improves antigen-specific T cell responses against human cytomegalovirus.

artículo científico publicado en 2013

DNA vaccines expressing glycoprotein complex II antigens gM and gN elicited neutralizing antibodies against multiple human cytomegalovirus (HCMV) isolates

artículo científico publicado en 2007

Focusing the immune response on the V3 loop, a neutralizing epitope of the HIV-1 gp120 envelope

artículo científico publicado en 2007

Gene-based adjuvants: a new meaning

artículo científico publicado en 2009

HIV-1 Env glycoproteins from two series of primary isolates: replication phenotype and immunogenicity

artículo científico publicado en 1997

Heterologous HA DNA vaccine prime--inactivated influenza vaccine boost is more effective than using DNA or inactivated vaccine alone in eliciting antibody responses against H1 or H3 serotype influenza viruses.

artículo científico publicado en 2008

Heterologous prime-boost vaccination.

scientific article published on 06 June 2009

Human versus HIV: round 2 defeat in AIDS vaccine development

artículo científico publicado en 2008

Immune responses and protection obtained with rotavirus VP6 DNA vaccines given by intramuscular injection

artículo científico publicado en 2001

Immunization of rhesus macaques with a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 vaccine elicits protective antibody response against simian human immunodeficiency virus of R5 phenotype

artículo científico publicado en 2006

Independent but not synergistic enhancement to the immunogenicity of DNA vaccine expressing HIV-1 gp120 glycoprotein by codon optimization and C3d fusion in a mouse model

artículo científico publicado en 2004

Influenza H5 hemagglutinin DNA primes the antibody response elicited by the live attenuated influenza A/Vietnam/1203/2004 vaccine in ferrets

artículo científico publicado en 2011

Intramuscular delivery of a cholera DNA vaccine primes both systemic and mucosal protective antibody responses against cholera

artículo científico publicado en 2009

Intranasal immunization with inactivated SARS-CoV (SARS-associated coronavirus) induced local and serum antibodies in mice.

artículo científico publicado en 2005

Introduction to this supplement

artículo científico publicado en 2009

Involvement of CD8+ T cell-mediated immune responses in LcrV DNA vaccine induced protection against lethal Yersinia pestis challenge ⬇️

artículo científico publicado el 9 de septiembre de 2011

Levels of N-linked glycosylation on the V1 loop of HIV-1 Env proteins and their relationship to the antigenicity of Env from primary viral isolates

artículo científico publicado en 2008

Measurement of neutralizing antibody responses against H5N1 clades in immunized mice and ferrets using pseudotypes expressing influenza hemagglutinin and neuraminidase

artículo científico publicado en 2009

Optimization and proficiency testing of a pseudovirus-based assay for detection of HIV-1 neutralizing antibody in China

artículo científico publicado en 2012

Passive immunotherapy of Bacillus anthracis pulmonary infection in mice with antisera produced by DNA immunization

artículo científico publicado en 2006

Pilot Study on the Use of DNA Priming Immunization to Enhance Y. pestis LcrV-Specific B Cell Responses Elicited by a Recombinant LcrV Protein Vaccine.

artículo científico publicado en 2013

Pilot study on the immunogenicity of paired Env immunogens from mother-to-child transmitted HIV-1 isolates

artículo científico publicado en 2012

Polyvalent AIDS Vaccines ⬇️

artículo científico publicado el 1 de diciembre de 2010

Polyvalent DNA prime and envelope protein boost HIV-1 vaccine elicits humoral and cellular responses and controls plasma viremia in rhesus macaques following rectal challenge with an R5 SHIV isolate

artículo científico publicado en 2005

Polyvalent HIV-1 Env vaccine formulations delivered by the DNA priming plus protein boosting approach are effective in generating neutralizing antibodies against primary human immunodeficiency virus type 1 isolates from subtypes A, B, C, D and E.

artículo científico publicado en 2006

Post-translational intracellular trafficking determines the type of immune response elicited by DNA vaccines expressing Gag antigen of Human Immunodeficiency Virus Type 1 (HIV-1)

scientific article published on 13 August 2013

Preclinical evaluation of cellular immune responses elicited by a polyvalent DNA prime/protein boost HIV-1 vaccine

artículo científico publicado en 2005

Profile of HIV-1 infected patients from an AIDS clinic in Beijing from 2007-2008.

artículo científico publicado en 2010

Profiles of B and T cell immune responses elicited by different forms of the hepatitis B virus surface antigen

artículo científico publicado en 2010

Profiles of human serum antibody responses elicited by three leading HIV vaccines focusing on the induction of Env-specific antibodies

artículo científico publicado en 2010

Progress on the induction of neutralizing antibodies against HIV type 1 (HIV-1).

artículo científico publicado en 2009

Protective antibody responses against Clostridium difficile elicited by a DNA vaccine expressing the enzymatic domain of toxin B.

artículo científico publicado en 2012

Relative contributions of codon usage, promoter efficiency and leader sequence to the antigen expression and immunogenicity of HIV-1 Env DNA vaccine

scientific article published on 18 August 2005

Removing N-terminal sequences in pre-S1 domain enhanced antibody and B-cell responses by an HBV large surface antigen DNA vaccine ⬇️

artículo científico publicado el 23 de julio de 2012

SIV DNA vaccine trial in macaques: post-challenge necropsy in vaccine and control groups

artículo científico publicado en 1997

Structure-guided design and immunological characterization of immunogens presenting the HIV-1 gp120 V3 loop on a CTB scaffold.

artículo científico publicado en 2010

The ability of Hepatitis B surface antigen DNA vaccine to elicit cell-mediated immune responses, but not antibody responses, was affected by the deglysosylation of S antigen

artículo científico publicado en 2008

The safety and tolerability of an HIV-1 DNA prime-protein boost vaccine (DP6-001) in healthy adult volunteers

artículo científico publicado en 2008

Timely development of vaccines against SARS-CoV-2

artículo científico publicado en 2020

Use of DNAs expressing HIV-1 Env and noninfectious HIV-1 particles to raise antibody responses in mice.

artículo científico publicado en 1995

Using DNA Immunization to Elicit Monoclonal Antibodies in Mice, Rabbits, and Humans

artículo científico publicado en 2018

Vaccinology: precisely tuned antibodies nab HIV.

artículo científico publicado en 2011

Lista de obras de Shan Lu

A DNA vaccine producing LcrV antigen in oligomers is effective in protecting mice from lethal mucosal challenge of plague

A versatile vector for the production of pseudotyped viruses expressing gp120 antigens from different clades of primary HIV-1 isolates.

Antibody responses elicited through homologous or heterologous prime-boost DNA and protein vaccinations differ in functional activity and avidity.

Antigen engineering can play a critical role in the protective immunity elicited by Yersinia pestis DNA vaccines.

Antigen engineering in DNA immunization

Clostridium difficile infections in China.

Co-expression of HIV-1 virus-like particles and granulocyte-macrophage colony stimulating factor by GEO-D03 DNA vaccine

Combination DNA plus protein HIV vaccines.

Construction and evaluation of replication-defective recombinant optimized triosephosphate isomerase adenoviral vaccination in Schistosoma japonicum challenged mice

Cross-clade neutralizing antibodies against HIV-1 induced in rabbits by focusing the immune response on a neutralizing epitope.

Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime-protein boost HIV-1 vaccine in healthy human volunteers

DNA Immunization for HIV Vaccine Development

DNA immunization

DNA prime-protein boost using subtype consensus Env was effective in eliciting neutralizing antibody responses against subtype BC HIV-1 viruses circulating in China.

DNA vaccine prime followed by boost with live attenuated virus significantly improves antigen-specific T cell responses against human cytomegalovirus.

DNA vaccines expressing glycoprotein complex II antigens gM and gN elicited neutralizing antibodies against multiple human cytomegalovirus (HCMV) isolates

Focusing the immune response on the V3 loop, a neutralizing epitope of the HIV-1 gp120 envelope

Gene-based adjuvants: a new meaning

HIV-1 Env glycoproteins from two series of primary isolates: replication phenotype and immunogenicity

Heterologous HA DNA vaccine prime--inactivated influenza vaccine boost is more effective than using DNA or inactivated vaccine alone in eliciting antibody responses against H1 or H3 serotype influenza viruses.

Heterologous prime-boost vaccination.

Human versus HIV: round 2 defeat in AIDS vaccine development

Immune responses and protection obtained with rotavirus VP6 DNA vaccines given by intramuscular injection

Immunization of rhesus macaques with a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 vaccine elicits protective antibody response against simian human immunodeficiency virus of R5 phenotype

Independent but not synergistic enhancement to the immunogenicity of DNA vaccine expressing HIV-1 gp120 glycoprotein by codon optimization and C3d fusion in a mouse model

Influenza H5 hemagglutinin DNA primes the antibody response elicited by the live attenuated influenza A/Vietnam/1203/2004 vaccine in ferrets

Intramuscular delivery of a cholera DNA vaccine primes both systemic and mucosal protective antibody responses against cholera

Intranasal immunization with inactivated SARS-CoV (SARS-associated coronavirus) induced local and serum antibodies in mice.

Introduction to this supplement

Involvement of CD8+ T cell-mediated immune responses in LcrV DNA vaccine induced protection against lethal Yersinia pestis challenge ⬇️

Levels of N-linked glycosylation on the V1 loop of HIV-1 Env proteins and their relationship to the antigenicity of Env from primary viral isolates

Measurement of neutralizing antibody responses against H5N1 clades in immunized mice and ferrets using pseudotypes expressing influenza hemagglutinin and neuraminidase

Optimization and proficiency testing of a pseudovirus-based assay for detection of HIV-1 neutralizing antibody in China

Passive immunotherapy of Bacillus anthracis pulmonary infection in mice with antisera produced by DNA immunization

Pilot Study on the Use of DNA Priming Immunization to Enhance Y. pestis LcrV-Specific B Cell Responses Elicited by a Recombinant LcrV Protein Vaccine.

Pilot study on the immunogenicity of paired Env immunogens from mother-to-child transmitted HIV-1 isolates

Polyvalent AIDS Vaccines ⬇️

Polyvalent DNA prime and envelope protein boost HIV-1 vaccine elicits humoral and cellular responses and controls plasma viremia in rhesus macaques following rectal challenge with an R5 SHIV isolate

Polyvalent HIV-1 Env vaccine formulations delivered by the DNA priming plus protein boosting approach are effective in generating neutralizing antibodies against primary human immunodeficiency virus type 1 isolates from subtypes A, B, C, D and E.

Post-translational intracellular trafficking determines the type of immune response elicited by DNA vaccines expressing Gag antigen of Human Immunodeficiency Virus Type 1 (HIV-1)

Preclinical evaluation of cellular immune responses elicited by a polyvalent DNA prime/protein boost HIV-1 vaccine

Profile of HIV-1 infected patients from an AIDS clinic in Beijing from 2007-2008.

Profiles of B and T cell immune responses elicited by different forms of the hepatitis B virus surface antigen

Profiles of human serum antibody responses elicited by three leading HIV vaccines focusing on the induction of Env-specific antibodies

Progress on the induction of neutralizing antibodies against HIV type 1 (HIV-1).

Protective antibody responses against Clostridium difficile elicited by a DNA vaccine expressing the enzymatic domain of toxin B.

Relative contributions of codon usage, promoter efficiency and leader sequence to the antigen expression and immunogenicity of HIV-1 Env DNA vaccine

Removing N-terminal sequences in pre-S1 domain enhanced antibody and B-cell responses by an HBV large surface antigen DNA vaccine ⬇️

SIV DNA vaccine trial in macaques: post-challenge necropsy in vaccine and control groups

Structure-guided design and immunological characterization of immunogens presenting the HIV-1 gp120 V3 loop on a CTB scaffold.

The ability of Hepatitis B surface antigen DNA vaccine to elicit cell-mediated immune responses, but not antibody responses, was affected by the deglysosylation of S antigen

The safety and tolerability of an HIV-1 DNA prime-protein boost vaccine (DP6-001) in healthy adult volunteers

Timely development of vaccines against SARS-CoV-2

Use of DNAs expressing HIV-1 Env and noninfectious HIV-1 particles to raise antibody responses in mice.

Using DNA Immunization to Elicit Monoclonal Antibodies in Mice, Rabbits, and Humans

Vaccinology: precisely tuned antibodies nab HIV.